AR003439A1 - Composicion de polisacaridos injertados con antioxidante y metodo para su preparacion. - Google Patents

Composicion de polisacaridos injertados con antioxidante y metodo para su preparacion.

Info

Publication number
AR003439A1
AR003439A1 ARP960103235A AR10323596A AR003439A1 AR 003439 A1 AR003439 A1 AR 003439A1 AR P960103235 A ARP960103235 A AR P960103235A AR 10323596 A AR10323596 A AR 10323596A AR 003439 A1 AR003439 A1 AR 003439A1
Authority
AR
Argentina
Prior art keywords
antioxidant
grafted
polysaccharides
preparation
composition
Prior art date
Application number
ARP960103235A
Other languages
English (en)
Original Assignee
Kusiys Martinas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR003439(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kusiys Martinas filed Critical Kusiys Martinas
Publication of AR003439A1 publication Critical patent/AR003439A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Abstract

Composiciones de polisacáridos injertados, que comprenden polisacáridos injertados con antioxidantes en por lo menos un grupo hidroxilo delpolisacárido. El uso de polisacáridos injertados con antioxidantes, o de polisacáridosentrecruzados injertados con antioxidantes, como un tratamientopara artritis, como un vehículo para la administración de drogas, para reducir la incidencia de la formación de adherencias postoperatorias, para estimularla curación de heridascrónicas y úlceras, y como un componente de formulaciones cosméticas. Se provee también un método para la preparación detales composiciones.
ARP960103235A 1995-06-22 1996-06-20 Composicion de polisacaridos injertados con antioxidante y metodo para su preparacion. AR003439A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/493,854 US5612321A (en) 1995-06-22 1995-06-22 Antioxidant grafted polysaccharides

Publications (1)

Publication Number Publication Date
AR003439A1 true AR003439A1 (es) 1998-08-05

Family

ID=23961969

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103235A AR003439A1 (es) 1995-06-22 1996-06-20 Composicion de polisacaridos injertados con antioxidante y metodo para su preparacion.

Country Status (15)

Country Link
US (1) US5612321A (es)
EP (1) EP0749982B2 (es)
JP (1) JPH0912603A (es)
KR (1) KR970001374A (es)
CN (1) CN1143084A (es)
AR (1) AR003439A1 (es)
AT (1) ATE196479T1 (es)
AU (1) AU699608B2 (es)
BR (1) BR9602856A (es)
CA (1) CA2179105A1 (es)
DE (1) DE69610370T3 (es)
DK (1) DK0749982T3 (es)
ES (1) ES2150050T5 (es)
PL (1) PL314905A1 (es)
RU (1) RU2174985C2 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0852236A4 (en) * 1995-09-19 2005-06-01 Seikagaku Kogyo Co Ltd ANTI-INFLAMMATORY AGENT
WO2000066599A1 (en) * 1999-04-30 2000-11-09 Oberthuer Walter Antioxidative vitamin b6 analogs
KR100326768B1 (ko) * 1999-07-16 2002-03-12 김근식 침 부항기
CN1221190C (zh) * 2001-02-09 2005-10-05 新纪元公司 解烟毒组合物和方法
GB0107653D0 (en) * 2001-03-27 2001-05-16 Bristol Myers Squibb Co Wound dressing
US6500947B1 (en) 2001-08-24 2002-12-31 Weyerhaeuser Company Superabsorbent polymer
KR100493461B1 (ko) * 2002-02-27 2005-06-07 재단법인서울대학교산학협력재단 접착분자가 부착된 천연고분자, 그의 제조방법 및 그의 용도
ITPD20020064A1 (it) 2002-03-12 2003-09-12 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem
US20040009210A1 (en) * 2002-07-09 2004-01-15 Kimberly-Clark Worldwide, Inc. Wound management products incorporating cationic compounds
US20040009141A1 (en) * 2002-07-09 2004-01-15 Kimberly-Clark Worldwide, Inc. Skin cleansing products incorporating cationic compounds
US20030035950A1 (en) * 2002-07-19 2003-02-20 Neogi Amar N. Superabsorbent cellulosic fiber
US20030034137A1 (en) * 2002-07-19 2003-02-20 Neogi Amar N. Superabsorbent cellulosic fiber
US20030024663A1 (en) * 2002-07-19 2003-02-06 Neogi Amar N. Superabsorbent cellulosic fiber
US20030034136A1 (en) * 2002-07-19 2003-02-20 Neogi Amar N. Superabsorbent cellulosic fiber
US7479507B2 (en) * 2003-01-14 2009-01-20 Adam Heller Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs
JP4694773B2 (ja) * 2003-06-06 2011-06-08 ロート製薬株式会社 粘膜適用液状組成物
GB2408206B (en) 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
AU2004248971A1 (en) * 2003-06-20 2004-12-29 Johnson & Johnson Medical Limited Antioxidant wound dressing materials
JP2007500027A (ja) * 2003-07-30 2007-01-11 アンタイス エス．エイ． 生物医学的な使用のための複合マトリックス
GB2408207A (en) 2003-11-24 2005-05-25 Johnson & Johnson Medical Ltd Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
ITMI20040347A1 (it) * 2004-02-26 2004-05-26 Pharma Medical Ltd Nuovo farmaco di associazione
US20060040894A1 (en) * 2004-08-13 2006-02-23 Angiotech International Ag Compositions and methods using hyaluronic acid
US7931030B2 (en) * 2004-12-30 2011-04-26 Genzyme Corporation Regimens for intra-articular viscosupplementation
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US9119901B2 (en) * 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
IL172477A (en) * 2005-12-08 2012-06-28 Univ Ben Gurion Addition of viscosity by algae polysaccharides to treat arthritis
FR2908415B1 (fr) * 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
GB2470940A (en) 2009-06-10 2010-12-15 Systagenix Wound Man Ip Co Bv Vacuum wound dressing with hydrogel layer
US20110077216A1 (en) * 2009-09-30 2011-03-31 Massachusetts Institute Of Technology Compositions and methods for the treatment of atherosclerosis and other related diseases
JP5518608B2 (ja) * 2010-07-09 2014-06-11 ロート製薬株式会社 粘膜適用液状組成物
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
AU2012282660B2 (en) * 2011-07-11 2017-07-27 The Children's Hospital Of Philadelphia Oxidation resistant bioprosthetic tissues and preparation thereof
FR2983483B1 (fr) 2011-12-02 2014-11-14 Vivacy Lab Procede de substitution et reticulation simultanees d'un polysaccharide via ses fonctions hydroxyles
WO2014095062A1 (en) * 2012-12-19 2014-06-26 University Of Geneva Hyaluronic acid - antioxidant conjugates and their uses
GB2518405A (en) * 2013-09-20 2015-03-25 Zeiss Carl Meditec Ag Composition comprising at least one viscoelastic polymer
US9877984B2 (en) 2013-12-23 2018-01-30 Massachusetts Institute Of Technology Controllably degradable compositions and methods
RU2619934C2 (ru) * 2015-10-28 2017-05-22 Федеральное Государственное Бюджетное Учреждение Науки Институт Химии Коми Научного Центра Уральского Отделения Российской Академии Наук Гидрофильный конъюгат производного крахмала и 2,6-диизоборнил-4-метилфенола и способ его получения
WO2017149584A1 (ja) * 2016-02-29 2017-09-08 川澄化学工業株式会社 癒着防止材
SG10202107829YA (en) 2017-03-22 2021-08-30 Genentech Inc Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
CN109206670B (zh) * 2017-07-03 2020-04-24 中国科学院化学研究所 一种含酚羟基的多糖衍生物的组合物及其制备方法和用途
RU2767207C1 (ru) * 2021-02-15 2022-03-16 Федеральное государственное бюджетное учреждение науки Федеральный исследовательский центр «Коми научный центр Уральского отделения Российской академии наук» Сульфатированный полисахарид на основе целлюлозы с привитым терпенофенолом, способ его получения и средство, обладающее антирадикальной, антиоксидантной и мембранопротекторной активностью
CN114478820B (zh) * 2022-02-25 2023-06-16 河北科技大学 一种多巴胺改性多糖及其制备方法和应用
CN114561013B (zh) * 2022-04-28 2022-07-19 富海(东营)新材料科技有限公司 一种临界相变萃取法提纯聚砜类树脂材料的工艺

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4863907A (en) * 1984-06-29 1989-09-05 Seikagaku Kogyo Co., Ltd. Crosslinked glycosaminoglycans and their use
SE456346B (sv) * 1984-07-23 1988-09-26 Pharmacia Ab Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
US4636524A (en) * 1984-12-06 1987-01-13 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4605691A (en) * 1984-12-06 1986-08-12 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
SE8501022L (sv) * 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
GB8713662D0 (en) † 1987-06-11 1987-07-15 Skandigen Ab Hyaluronic acid derivatives
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
DE3900198A1 (de) † 1989-01-05 1990-07-12 Merck Patent Gmbh Topisch anwendbare pharmazeutische zubereitung
SE8900586L (sv) * 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US5356883A (en) * 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
US5429856A (en) * 1990-03-30 1995-07-04 Minnesota Mining And Manufacturing Company Composite materials and process
GR920100122A (el) * 1991-04-05 1993-03-16 Ethicon Inc Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως.
US5384187A (en) * 1991-05-15 1995-01-24 Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha Biodegradable resin compositions and laminates based thereon
GB9225581D0 (en) † 1992-12-08 1993-01-27 Courtaulds Plc Wound dressings
US5492943A (en) * 1994-06-20 1996-02-20 Hollister Incorporated Adhesive skin barrier composition for ostomy appliance

Also Published As

Publication number Publication date
PL314905A1 (en) 1996-12-23
DE69610370T2 (de) 2001-03-01
RU2174985C2 (ru) 2001-10-20
ATE196479T1 (de) 2000-10-15
DE69610370D1 (de) 2000-10-26
EP0749982A1 (en) 1996-12-27
AU699608B2 (en) 1998-12-10
CN1143084A (zh) 1997-02-19
EP0749982B1 (en) 2000-09-20
KR970001374A (ko) 1997-01-24
CA2179105A1 (en) 1996-12-23
AU5612596A (en) 1997-01-09
BR9602856A (pt) 1998-04-28
ES2150050T3 (es) 2000-11-16
US5612321A (en) 1997-03-18
ES2150050T5 (es) 2005-03-01
JPH0912603A (ja) 1997-01-14
DK0749982T3 (da) 2000-12-11
DE69610370T3 (de) 2005-03-17
EP0749982B2 (en) 2004-09-01

Similar Documents

Publication Publication Date Title
AR003439A1 (es) Composicion de polisacaridos injertados con antioxidante y metodo para su preparacion.
ES2158611T3 (es) Composicion en gel inyectable con efecto retard y procedimiento para la preparacion de dicha composicion.
WO2003004000A3 (en) Topical composition for treating pain
AP9801367A0 (en) Composition, barrier film, and method for preventing contact dermatitis.
MX9306495A (es) Copolimeros que contienen (met) acrilato funcional de hidroxilo- impedido, apropiados porticularmente para usarse para revestir composiciones que se rocian con fluidos comprimidos con diluyentes reductores de viscosidad.
BR0015604A (pt) Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas
PA8479201A1 (es) Derivados del acido hidroxi-pipecolato hidroxamico
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
HK1018394A1 (en) Composition for acceleration of wound and burn healing as well as a wound or burn dressing
MX9704735A (es) Formulaciones para reducir irritacion de la piel y el uso de las mismas.
KR900700128A (ko) 외상 치료법
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
AR004701A1 (es) 2-azetidinonas substituidas con azucares utiles como agentes hipocolesterolemicos, composicion farmaceutica, proceso para la preparacion dedicha composicion, uso de dichos compuestos para fabricar medicamentos y un equipo.
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
HUP9902287A1 (hu) Szintetikus poliszacharidok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
AU7742594A (en) Novel compositions
AU2002227052A1 (en) Treatments for neurogenetic disorders, impulse control disorders, and wound healing
ATE67662T1 (de) Topische antibiotische zusammensetzung zur behandlung der schleimhaeute.
ES2054098T3 (es) Uso de minoxidilo para la curacion de heridas.
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.